Plasma Neuronal and Glial Markers and Anterior Cingulate Metabolite Levels in Major Depressive Disorder: A Pilot Study
The DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.
Abstract
Introduction: Neuroglial functions may be deteriorated in major depressive disorder (MDD). Objective: To evaluate the markers of glial and neuronal cell turnover and to explore their associations with brain metabolites. Methods: In 10 participants with MDD and 10 healthy controls (HC) we investigated neuronal and glial plasma markers (the neuron-specific enolase, NSE; and S100beta, S100B) and brain metabolites (N-acetyl aspartate, NAA; total choline, Cho; and total creatine, Cr). Blood was collected for NSE and S100B. NAA, Cho, and Cr metabolite levels were measured in the anterior cingulate cortex (ACC) with proton magnetic resonance spectroscopy (1 H-MRS) at 3T. Results: NSE and S100B levels were significantly higher in MDD subjects than in HC. The Cr level was significantly higher in MDD subjects than in HC, but the NAA and Cho levels did not differ between groups. NAA/Cr and Cho/Cr ratios were significantly lower in patients with MDD versus HC. S100B was negatively correlated with the Cho levels. Conclusions: These results provide supporting evidence of neuronal and glial distress in MDD. Neuronal viability appears decreased, whereas glial regenerative activity and energy metabolism in the ACC increase in acute major depressive episode. Since low concentrations of S100B have neuroplastic effects, these changes may indicate a possible compensatory mechanism.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“S100B levels are elevated in the CSF or serum of patients with MDD, 180”
From Major depressive disorder: hypothesis, mechanism, prevention and treatment (2024) · cites this paper as [180]
Citations
Cites
Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975) · Journal of Psychiatric Research · doi:10.1016/0022-3956(75)90026-6 · Cited by 88,282
Hamilton, M. (1960) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.23.1.56 · Cited by 32,817
The S100 family of EF-hand calcium-binding proteins: functions and pathology
SCHAFER, B. (1996) · Trends in Biochemical Sciences · doi:10.1016/0968-0004(96)10020-7 · Cited by 999
The S100 protein family: History, function, and expression
Zimmer, D. B., Cornwall, E. H., Landar, A., & Song, W. (1995) · Brain Research Bulletin · doi:10.1016/0361-9230(95)00040-2 · Cited by 927
The S100 family of EF-hand calcium-binding proteins: functions and pathology
Schäfer, B. W., & Heizmann, C. W. (1996) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(96)80167-8 · Cited by 682
S100B in brain damage and neurodegeneration
Rothermundt, M., Peters, M., Prehn, J. H. M., & Arolt, V. (2003) · Microscopy Research and Technique · doi:10.1002/jemt.10303 · Cited by 609
A probability-based measure of effect size: Robustness to base rates and other factors.
Ruscio, J. (2008) · Psychological Methods · doi:10.1037/1082-989x.13.1.19 · Cited by 398
Evidence for a wide extra-astrocytic distribution of S100B in human brain
Steiner, J., Bernstein, H.-G., Bielau, H., Berndt, A., Brisch, R., Mawrin, C., Keilhoff, G., & Bogerts, B. (2007) · BMC Neuroscience · doi:10.1186/1471-2202-8-2 · Cited by 283
Haque, A., Polcyn, R., Matzelle, D., & Banik, N. L. (2018) · Brain Sciences · doi:10.3390/brainsci8020033 · Cited by 244
Luykx, J. J., Laban, K. G., van den Heuvel, M. P., Boks, M. P. M., Mandl, R. C. W., Kahn, R. S., & Bakker, S. C. (2012) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2011.05.014 · Cited by 235
SHENG, J. G., MRAK, R. E., & T. GRIFFIN, W. S. (1997) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199703000-00007 · Cited by 215
Godfrey, K. E. M., Gardner, A. C., Kwon, S., Chea, W., & Muthukumaraswamy, S. D. (2018) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2018.08.015 · Cited by 206
Böhmer, A. E., Oses, J. P., Schmidt, A. P., Perón, C. S., Krebs, C. L., Oppitz, P. P., D'Avila, T. T., Souza, D. O., Portela, L. V., & Stefani, M. A. (2011) · Neurosurgery · doi:10.1227/neu.0b013e318214a81f · Cited by 184
Meier, T. B., Drevets, W. C., Wurfel, B. E., Ford, B. N., Morris, H. M., Victor, T. A., Bodurka, J., Teague, T. K., Dantzer, R., & Savitz, J. (2016) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2015.11.003 · Cited by 175
Cholinergic mechanisms in depression
Dilsaver, S. C. (1986) · Brain Research Reviews · doi:10.1016/0165-0173(86)90016-0 · Cited by 173
Yuan, P., Zhou, R., Wang, Y., Li, X., Li, J., Chen, G., Guitart, X., & Manji, H. K. (2010) · Journal of Affective Disorders · doi:10.1016/j.jad.2009.10.017 · Cited by 161
Serum markers support disease-specific glial pathology in major depression
Schroeter, M. L., Abdul-Khaliq, H., Krebs, M., Diefenbacher, A., & Blasig, I. E. (2008) · Journal of Affective Disorders · doi:10.1016/j.jad.2008.03.005 · Cited by 152
Brain Bioenergetics and Response to Triiodothyronine Augmentation in Major Depressive Disorder
Iosifescu, D. V., Bolo, N. R., Nierenberg, A. A., Jensen, J. E., Fava, M., & Renshaw, P. F. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2007.11.020 · Cited by 139
Self-citationActive secretion of S100B from astrocytes during metabolic stress
Gerlach, R., Demel, G., König, H., Groß, U., Prehn, J. H. M., Raabe, A., Seifert, V., & Kögel, D. (2006) · Neuroscience · doi:10.1016/j.neuroscience.2006.05.008 · Cited by 137
S100B and response to treatment in major depression: a pilot study
Arolt, V., Peters, M., Erfurth, A., Wiesmann, M., Missler, U., Rudolf, S., Kirchner, H., & Rothermundt, M. (2003) · European Neuropsychopharmacology · doi:10.1016/s0924-977x(03)00016-6 · Cited by 135
Steiner, J., Schiltz, K., Walter, M., Wunderlich, M. T., Keilhoff, G., Brisch, R., Bielau, H., Bernstein, H., Bogerts, B., Schroeter, M. L., et al. (2009) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2009.07.012 · Cited by 126
1H MR spectroscopy of inflammation, infection and ischemia of the brain
Mader, I., Rauer, S., Gall, P., & Klose, U. (2008) · European Journal of Radiology · doi:10.1016/j.ejrad.2008.02.033 · Cited by 126
S100B is increased in mood disorders and may be reduced by antidepressive treatment
Schroeter, M. L., Abdul-Khaliq, H., Diefenbacher, A., & Blasig, I. E. (2002) · NeuroReport · doi:10.1097/00001756-200209160-00021 · Cited by 124
Persistent β 2 *-Nicotinic Acetylcholinergic Receptor Dysfunction in Major Depressive Disorder
Saricicek, A., Esterlis, I., Maloney, K. H., Mineur, Y. S., Ruf, B. M., Muralidharan, A., Chen, J. I., Cosgrove, K. P., Kerestes, R., Ghose, S., et al. (2012) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2012.11101546 · Cited by 118
Merkl, A., Schubert, F., Quante, A., Luborzewski, A., Brakemeier, E., Grimm, S., Heuser, I., & Bajbouj, M. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2010.08.009 · Cited by 115
Pinto, S. S., Gottfried, C., Mendez, A., Gonçalves, D., Karl, J., Gonçalves, C. A., Wofchuk, S., & Rodnight, R. (2000) · FEBS Letters · doi:10.1016/s0014-5793(00)02301-2 · Cited by 115
S-100B is increased in melancholic but not in non-melancholic major depression
Rothermundt, M., Arolt, V., Wiesmann, M., Missler, U., Peters, M., Rudolf, S., & Kirchner, H. (2001) · Journal of Affective Disorders · doi:10.1016/s0165-0327(00)00321-9 · Cited by 107
Streitbürger, D. P., Arélin, K., Kratzsch, J., Thiery, J., Steiner, J., Villringer, A., Mueller, K., & Schroeter, M. L. (2012) · PLoS ONE · doi:10.1371/journal.pone.0043284 · Cited by 93
Hetzel, G., Moeller, O., Evers, S., Erfurth, A., Ponath, G. D., Arolt, V., & Rothermundt, M. (2004) · Psychopharmacology · doi:10.1007/s00213-004-1999-z · Cited by 93
Does escitalopram reduce neurotoxicity in major depression?
Halaris, A., Myint, A.-M., Savant, V., Meresh, E., Lim, E., Guillemin, G., Hoppensteadt, D., Fareed, J., & Sinacore, J. (2015) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2015.04.026 · Cited by 86
Ahmad, O., Wardlaw, J. M., & Whiteley, W. N. (2011) · Cerebrovascular Diseases · doi:10.1159/000332810 · Cited by 80
Kondo, D. G., Forrest, L. N., Shi, X., Sung, Y.-H., Hellem, T. L., Huber, R. S., & Renshaw, P. F. (2016) · Amino Acids · doi:10.1007/s00726-016-2194-3 · Cited by 79
Neurotrophic Factor S100beta in Major Depression
Grabe, H. J., Ahrens, N., Rose, H.-J., Kessler, C., & Freyberger, H. J. (2001) · Neuropsychobiology · doi:10.1159/000054922 · Cited by 75
Forester, B. P., Harper, D. G., Jensen, J. E., Ravichandran, C., Jordan, B., Renshaw, P. F., & Cohen, B. M. (2009) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.2230 · Cited by 75
Chen, L., Dai, H., Dai, Z., Xu, C., & Wu, R. (2014) · Psychiatry and Clinical Neurosciences · doi:10.1111/pcn.12138 · Cited by 71
Yoon, S., Kim, J. E., Hwang, J., Kim, T.-S., Kang, H. J., Namgung, E., Ban, S., Oh, S., Yang, J., Renshaw, P. F., et al. (2016) · Biological Psychiatry · doi:10.1016/j.biopsych.2015.11.027 · Cited by 71
S100B Serum Levels Predict Treatment Response in Patients with Melancholic Depression
Ambrée, O., Bergink, V., Grosse, L., Alferink, J., Drexhage, H. A., Rothermundt, M., Arolt, V., & Birkenhäger, T. K. (2016) · International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyv103 · Cited by 71
Tissue Type-Specific Bioenergetic Abnormalities in Adults with Major Depression
Harper, D. G., Jensen, J. E., Ravichandran, C. T., Perlis, R. H., Fava, M., Renshaw, P. F., & Iosifescu, D. V. (2016) · Neuropsychopharmacology · doi:10.1038/npp.2016.180 · Cited by 69
Self-citationAdrenergic-cholinergic balance and the treatment of affective disorders
Janowsky, D. S., Risch, S. C., & Gillin, J. C. (1983) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/0278-5846(83)90119-7 · Cited by 66
High Glutamate Decreases S100B Secretion by a Mechanism Dependent on the Glutamate Transporter
Tramontina, F. F., Leite, M. C., Gonçalves, D. D. S., Tramontina, A. C., Souza, D. F., Frizzo, J. K., Nardin, P., Gottfried, C., Wofchuk, S. T., & Gonçalves, C. (2006) · Neurochemical Research · doi:10.1007/s11064-006-9085-z · Cited by 59
Jang, B., Kim, H. R., Lim, S., Jang, K.-W., & Kim, D. (2008) · Psychiatry Investigation · doi:10.4306/pi.2008.5.3.193 · Cited by 49
Yang, K., Xie, G., Hu, Y.-Q., Mao, F., & Su, L. (2008) · Journal of Neural Transmission · doi:10.1007/s00702-008-0130-8 · Cited by 48
Olvera, R. L., Caetano, S. C., Stanley, J. A., Chen, H.-H., Nicoletti, M., Hatch, J. P., Fonseca, M., Pliszka, S. R., & Soares, J. C. (2010) · Psychiatry Research Neuroimaging · doi:10.1016/j.pscychresns.2010.07.008 · Cited by 43
Low left amygdala volume is associated with a longer duration of unipolar depression
Zavorotnyy, M., Zöllner, R., Schulte-Güstenberg, L. R., Wulff, L., Schöning, S., Dannlowski, U., Kugel, H., Arolt, V., & Konrad, C. (2017) · Journal of Neural Transmission · doi:10.1007/s00702-017-1811-y · Cited by 40
Tae, W. S., Kim, S. S., Lee, K. U., Nam, E.-C., & Koh, S. H. (2014) · Acta Radiologica · doi:10.1177/0284185113502744 · Cited by 39
Schmitt, K. R. L., Kern, C., Lange, P., Berger, F. F., Abdul‐Khaliq, H., & Hendrix, S. (2007) · Neuroscience Research · doi:10.1016/j.neures.2007.05.011 · Cited by 37
Henigsberg, N., Šarac, H., Radoš, M., Radoš, M., Ozretić, D., Foro, T., Turk, V. E., Hrabač, P., Janović, M. B., Rak, B., et al. (2017) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2017.00277 · Cited by 34
Dietrich, D. E., Hauser, U., Peters, M., Zhang, Y., Wiesmann, M., Hasselmann, M., Rudolf, S., Jüngling, O., Kirchner, H., Münte, T. F., et al. (2003) · Neuroscience Letters · doi:10.1016/j.neulet.2003.09.062 · Cited by 33
Schmidt, F. M., Mergl, R., Stach, B., Jahn, I., & Schönknecht, P. (2015) · The World Journal of Biological Psychiatry · doi:10.3109/15622975.2014.952776 · Cited by 33
Zhang, Y., Han, Y. K., Wang, Y., Zhang, Y., Li, L., Jin, E., Deng, L., Watts, B., Golden, T. A., & Wu, N. (2015) · BMC Psychiatry · doi:10.1186/s12888-015-0489-7 · Cited by 30
Wiener, C. D., Jansen, K., Ghisleni, G., Kaster, M. P., Souza, L. D. D. M., Lara, D. R., Portela, L. V., da Silva, R. A., & Oses, J. P. (2013) · Neurochemical Research · doi:10.1007/s11064-013-1036-x · Cited by 29
Proton spectroscopy study of the dorsolateral prefrontal cortex in youth with familial depression
Yang, X., Langevin, L. M., Jaworska, N., Kirton, A., Lebel, R. M., Harris, A. D., Jasaui, Y., Wilkes, T. C., Sembo, M., Swansburg, R., et al. (2016) · Psychiatry and Clinical Neurosciences · doi:10.1111/pcn.12392 · Cited by 27
Maier, H. B., Helm, S., Toto, S., Moschny, N., Sperling, W., Hillemacher, T., Kahl, K. G., Jakubovski, E., Bleich, S., Frieling, H., et al. (2018) · Disease Markers · doi:10.1155/2018/2358451 · Cited by 15
Neuron-specific enolase levels in drug-naïve young adults with major depressive disorder
Wiener, C. D., Molina, M. L., dos Passos, M. B., Moreira, F. P., Bittencourt, G., Souza, L. D. D. M., da Silva, R. A., Jansen, K., & Oses, J. P. (2016) · Neuroscience Letters · doi:10.1016/j.neulet.2016.03.049 · Cited by 7
Cited by
Major depressive disorder: hypothesis, mechanism, prevention and treatment
Cui, L., Li, S., Wang, S., Wu, X., Liu, Y., Yu, W., Wang, Y., Tang, Y., Xia, M., & Li, B. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01738-y · Cited by 1,244
“…in the dorsolateral prefrontal cortex (dlPFC) of patients with MDD. 179 S100B levels are elevated in the CSF or serum of patients with MDD, 180 which suggests that S100B is a potential diagnostic biomarker for depressive episodes associated with MDD. Communication between neurons and…”
BackgroundO'Leary, L. A., & Mechawar, N. (2021) · Glia · doi:10.1002/glia.23994 · Cited by 124
“…been consistently correlated with MDD as a state marker in unmedicated patients, and some studies have shown they correlate with symptom severity and their normalization is predictive of successful treatment response (Ambrée et al., 2016; Fang et al., 2016; Gulen et al., 2016; Güleş et al., 2020).”
ResultKantrowitz, J. T., Dong, Z., Milak, M. S., Rashid, R., Kegeles, L. S., Javitt, D. C., Lieberman, J. A., & John Mann, J. (2021) · Translational Psychiatry · doi:10.1038/s41398-021-01541-1 · Cited by 100
“While a few [66, 67] but not all [68] studies suggest that NAA altered in MDD, this limitation was minimized by the lack of between-group differences for NAA, and the confirmatory analysis using Cr as a reference.”
ResultEnergy metabolism in major depressive disorder: Recent advances from omics technologies and imaging
Gu, X., Ke, S., Wang, Q., Zhuang, T., Xia, C., Xu, Y., Yang, L., & Zhou, M. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.111869 · Cited by 99
Steinacker, P., Al Shweiki, M. R., Oeckl, P., Graf, H., Ludolph, A. C., Schönfeldt-Lecuona, C., & Otto, M. (2021) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2021.09.012 · Cited by 84
Metadata
- Authors
- Güleş, E., Iosifescu, D. V., & Tural, Ü.
- Affiliations
- Kocaeli Üniversitesi (TR)
- Nathan Kline Institute for Psychiatric Research (US)
- Venue
- Neuropsychobiology
- Publisher
- S. Karger AG
- Published
- 2020
- Volume
- 79
- Issue
- 3
- Pages
- 214-221
- ISSN
- 0302-282X (ISSN-L)
- 1423-0224
- OpenAlex
- W3005586777
- Cited by
- 42
- References
- 53
- Citations by year
- 2026: 11 · 2025: 3 · 2024: 6 · 2023: 8 · 2022: 5 · 2021: 8 · 2020: 1
- FWCI
- 3.30
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.karger.com/Services/SiteLicenses (vor)
- www.karger.com/Services/SiteLicenses (tdm)
- Locations
- Neuropsychobiology (publishedVersion)
- PubMed (publishedVersion)
- Kocaeli Üniversitesi - AVESİS (submittedVersion)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
- Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
- Keywords
- major depressive disorder, plasma biomarkers, neuron-specific enolase, S100B, glial activity, anterior cingulate cortex, brain metabolites, N-acetylaspartate, choline, creatine, 1H NMR, neuroplasticity, neuronal viability, energy metabolism
- MeSH terms
- Adult, Aspartic Acid, Choline, Creatine, Major Depressive Disorder, Depressive Disorder, Major, Female, Gyrus Cinguli, Humans, Male, Middle Aged, Phosphopyruvate Hydratase, Pilot Projects, S100 Calcium Binding Protein beta Subunit, Proton Magnetic Resonance Spectroscopy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.